Clinical Trial Update: Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer [EARLY_Phase 1]

View source ↗

Summary

This open-label early-phase 1 pilot study evaluates contrast-enhanced ultrasound for assessing renal lesions in patients with kidney cancer; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Kidney Cancer | EARLY_Phase 1 | Status: COMPLETED